We are building AI to expand the boundaries of medicine
Our quantum chemistry AI platform, powered by an industry-leading chemoproteomics data generation engine, learns the rules of molecular reactivity, making programmable small molecule drug design a reality. With any protein target now within reach, we are generating a pipeline of potential first-in-class candidates, starting with unmet needs in oncology, immunology, and other well-defined diseases.